Mineralocorticoid Action: Target Tissue Specificity Is Enzyme, Not Receptor, Mediated
The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Abstract
Mineralocorticoid receptors, both when in tissue extracts and when recombinant-derived, have equal affinity for the physiological mineralocorticoid aldosterone and for the glucocorticoids cortisol and corticosterone, which circulate at much higher concentrations than aldosterone. Such receptors are found in physiological mineralocorticoid target tissues (kidney, parotid, and colon) and in nontarget tissues such as hippocampus and heart. In mineralocorticoid target tissues the receptors are selective for aldosterone in vivo because of the presence of the enzyme 11 β-hydroxy-steroid dehydrogenase, which converts cortisol and corticosterone, but not aldosterone, to their 11-keto analogs. These analogs cannot bind to mineralocorticoid receptors.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In mineralocorticoid-responsive tissues such as the kidney, cortisol is enzymatically converted to cortisone, a metabolically inactive steroid (569).”
From The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders (2011) · cites this paper as [569]
In the citing paper
“Thus, the type 2 enzyme inactivates the mineralocorticoid activity of cortisol in the kidney tubule (569), and inactivating mutations in the type 2 enzyme cause a syndrome of apparent mineralocorticoid excess (AME) (588).”
From The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders (2011) · cites this paper as [569]
In the citing paper
“Thus, 11HSD2 prevents cortisol from overwhelming renal mineralocorticoid receptors (569), and in the placenta and other fetal tissues 11HSD2 (583, 584) also inactivates cortisol.”
From The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders (2011) · cites this paper as [569]
In the citing paper
“The kidney has high levels of HSD11B2 activity which protects the mineralocorticoid receptor from activation by cortisol by inactivating it to cortisone (Edwards and Stewart, 1991, Funder et al., 1988).”
From Intracrine androgen biosynthesis, metabolism and action revisited (2018) · cites this paper as Funder et al., 1988
Citations
Cites
The Steroid and Thyroid Hormone Receptor Superfamily
Evans, R. M. (1988) · Science · doi:10.1126/science.3283939 · Cited by 7,439
Arriza, J. L., Weinberger, C., Cerelli, G., Glaser, T. M., Handelin, B. L., Housman, D. E., & Evans, R. M. (1987) · Science · doi:10.1126/science.3037703 · Cited by 1,946
Stewart, P., Valentino, R., Wallace, A. M., Burt, D., Shackleton, C. L., & Edwards, C. W. (1987) · The Lancet · doi:10.1016/s0140-6736(87)91014-2 · Cited by 803
Krozowski, Z. S., & Funder, J. W. (1983) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.80.19.6056 · Cited by 523
Self-citationThe Roles of Plasma Binding and Receptor Specificity in the Mineralocorticoid Action of Aldosterone1
FUNDER, J. W., FELDMAN, D., & EDELMAN, I. S. (1973) · Endocrinology · doi:10.1210/endo-92-4-994 · Cited by 232
Self-citationCharacterization of Rat Brain Aldosterone Receptors Reveals High Affinity for Corticosterone
BEAUMONT, K., & FANESTIL, D. D. (1983) · Endocrinology · doi:10.1210/endo-113-6-2043 · Cited by 193
Pearson Murphy, B. E. (1981) · Journal of Steroid Biochemistry · doi:10.1016/0022-4731(81)90226-0 · Cited by 178
Glucocorticoid Receptors in Rat Kidney: The Rinding of Tritiated-Dexamethasone1
FUNDER, J. W., FELDMAN, D., & EDELMAN, I. S. (1973) · Endocrinology · doi:10.1210/endo-92-4-1005 · Cited by 173
Self-citationAFFINITY OF LIQUORICE DERIVATIVES FOR MINERALOCORTICOID AND GLUCOCORTICOID RECEPTORS
ARMANINI, D., KARBOWIAK, I., & FUNDER, J. W. (1983) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1983.tb00038.x · Cited by 157
Self-citationGlucocorticoid and mineralocorticoid receptors for aldosterone
Rousseau, G. G., Baxter, J. D., Funder, J. W., Edelman, I. S., & Tomkins, G. M. (1972) · Journal of Steroid Biochemistry · doi:10.1016/0022-4731(72)90053-2 · Cited by 151
Self-citation
Research works printed but not linked: 4
- Krozowski, Z. S., Proceedings of the National Academy of Sciences of the United States of America 80: 6056 (1983).
- SHEPPARD, K, MINERALOCORTICOID SPECIFICITY OF RENAL TYPE-I RECEPTORS - INVIVO BINDING-STUDIES, AMERICAN JOURNAL OF PHYSIOLOGY 252: E224 (1987).
- SHEPPARD, K, TYPE-I RECEPTORS IN PAROTID, COLON, AND PITUITARY ARE ALDOSTERONE SELECTIVE INVIVO, AMERICAN JOURNAL OF PHYSIOLOGY 253: E467 (1987).
- STEWART, P.M., CORTICOSTEROIDS PEPT 39: 163 (1987).
Cited by
Items 701–800 of 1,001
Craigie, E., Evans, L. C., Mullins, J. J., & Bailey, M. A. (2012) · Hypertension · doi:10.1161/hypertensionaha.112.196410 · Cited by 40
Replacement therapy for Addison's disease: recent developments
Løvås, K., & Husebye, E. S. (2008) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.17.4.497 · Cited by 32
“, oxidised) locally in mineralocorticoid target tissues by the enzyme 11 β -hydroxysteroid dehydrogenase type 2 (11 β -HSD2) [29] .”
BackgroundAsao, T., Oki, K., Yoneda, M., Tanaka, J., & Kohno, N. (2015) · Endocrine Journal · doi:10.1507/endocrj.ej15-0360 · Cited by 40
Meijer, O. C., Karssen, A. M., & de Kloet, E. R. (2003) · Journal of Endocrinology · doi:10.1677/joe.0.1780013 · Cited by 40
“mineralocorticoid receptors (MRs) in a number of tissues, such as the distal nephron (Edwards et al. 1988, Funder et al. 1988 ) and brain (Robson et al. 1998).”
Characterization of human trophoblast as a mineralocorticoid target tissue
Driver, P. M., Rauz, S., Walker, E. A., Hewison, M., Kilby, M. D., & Stewart, P. M. (2003) · Molecular Human Reproduction · doi:10.1093/molehr/gag091 · Cited by 40
“Aldosterone (Aldo) gains access to the MR in vivo due to `pre-receptor metabolism' of cortisol (F) to inactive cortisone (E) by the type 2 isozyme of 11b-hydroxysteroid dehydrogenase (11b-HSD2) (Edwards et al., 1988; Funder et al., 1988).”
BackgroundSouness, G. W., Brem, A. S., & Morris, D. J. (2002) · Steroids · doi:10.1016/s0039-128x(01)00148-9 · Cited by 40
Aldosterone and mineralocorticoid receptors: Orphan questions
Funder, J. W. (2000) · Kidney International · doi:10.1046/j.1523-1755.2000.00975.x · Cited by 40
Self-citationYamanaka, R., Otsuka, F., Nakamura, K., Yamashita, M., Otani, H., Takeda, M., Matsumoto, Y., KUSANO, K. F., Ito, H., & Makino, H. (2010) · Hypertension Research · doi:10.1038/hr.2010.16 · Cited by 39
Role of aldosterone availability in preeclampsia
Escher, G., & Mohaupt, M. (2007) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2007.03.002 · Cited by 39
Getting to the heart of intracellular glucocorticoid regeneration: 11β-HSD1 in the myocardium
Gray, G. A., White, C. I., Castellan, R. F. P., McSweeney, S. J., & Chapman, K. E. (2016) · Journal of Molecular Endocrinology · doi:10.1530/jme-16-0128 · Cited by 39
The mineralocorticoid receptor—an emerging player in metabolic syndrome?
Thuzar, M., & Stowasser, M. (2021) · Journal of Human Hypertension · doi:10.1038/s41371-020-00467-3 · Cited by 40
Shekhtman, E., Geerling, J. C., & Loewy, A. D. (2007) · The Journal of Comparative Neurology · doi:10.1002/cne.21245 · Cited by 39
The Role of Aldosterone in Renal Sodium Transport
Rozansky, D. J. (2006) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2005.09.008 · Cited by 39
Eyre, L. J., Rabbitt, E. H., Bland, R., Hughes, S. V., Cooper, M. S., Sheppard, M. C., Stewart, P. M., & Hewison, M. (2001) · Journal of Cellular Biochemistry · doi:10.1002/1097-4644(20010601)81:3<453::aid-jcb1059>3.0.co;2-z · Cited by 35
Latif, S. A., Sheff, M. F., Ribeiro, C. E., & Morris, D. J. (1997) · Steroids · doi:10.1016/s0039-128x(96)00208-5 · Cited by 40
Brain Mineralocorticoid Receptor Control of Blood Pressure and Kidney Function in Normotensive Rats
Rahmouni, K., Barthelmebs, M., Grima, M., Imbs, J., & de Jong, W. (1999) · Hypertension · doi:10.1161/01.hyp.33.5.1201 · Cited by 39
Impact of excess aldosterone on glucose homeostasis in adult male rat
Selvaraj, J., Muthusamy, T., Srinivasan, C., & Balasubramanian, K. (2009) · Clinica Chimica Acta · doi:10.1016/j.cca.2009.06.030 · Cited by 38
Biwer, L. A., Wallingford, M. C., & Jaffe, I. Z. (2018) · American Journal of Hypertension · doi:10.1093/ajh/hpy158 · Cited by 38
Kim, S. W., de Seigneux, S., Sassen, M. C., Lee, J., Kim, J., Knepper, M. A., Frøkiær, J., & Nielsen, S. (2005) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00084.2005 · Cited by 38
“It has been suggested that the activity of 11 HSD2 can regulate sodium reabsorption in aldosterone-responsive renal tubules by glucocorticoid-induced activation of MR (17, 34).”
BackgroundWoitge, H. W., Harrison, J. R., Ivkošić, A., Krozowski, Z. S., & Kream, B. E. (2001) · Endocrinology · doi:10.1210/endo.142.3.8044 · Cited by 38
Determinants of spironolactone binding specificity in the mineralocorticoid receptor
Rogerson, F. M., Yao, Y., Smith, B. J., Dimopoulos, N., & Fuller, P. J. (2003) · Journal of Molecular Endocrinology · doi:10.1677/jme.0.0310573 · Cited by 38
“Both receptors bind cortisol and corticosterone with high affinity, whereas only the MR binds aldosterone with high affinity (Funder et al. 1988).”
BackgroundMineralocorticoid modulation of central control of blood pressure
Sánchez, E. P. G. (1995) · Steroids · doi:10.1016/0039-128x(94)00004-v · Cited by 38
Aldosterone and Aldosterone Antagonism in Cardiovascular Disease: Focus on Eplerenone (Inspra)
Stier, C. T., Koenig, S., Lee, D. Y., Chawla, M. K., & Frishman, W. H. (2003) · Heart Disease · doi:10.1097/01.hdx.0000061698.20666.aa · Cited by 38
Pizzolo, F., Friso, S., Morandini, F., Antoniazzi, F., Zaltron, C., Udali, S., Gandini, A., Cavarzere, P., Salvagno, G. L., Giorgetti, A., et al. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-1760 · Cited by 37
“If 11 -HSD2 is defective, more cortisol is therefore available to MR binding, resulting in a higher MR activation (3, 4).”
Leung, J. C. K., Chan, L. Y. Y., Tang, S. C. W., Lam, M.-F., Chow, C.-W., Lim, A.-I., & Lai, K. N. (2011) · Journal of Translational Medicine · doi:10.1186/1479-5876-9-169 · Cited by 37
“Previously, it is believed that the specificity for MR to Aldo is conferred enzymatically by the cortisol-inactivating enzyme 11b-HSD2 [29,30].”
BackgroundProgestin withdrawal at parturition in the mare
Legacki, E. L., Corbin, C. J., Ball, B. A., Wynn, M. A. A., Loux, S. C., Stanley, S. D., & Conley, A. J. (2016) · Reproduction · doi:10.1530/rep-16-0227 · Cited by 37
Pseudohyperaldosteronism: Pathogenetic Mechanisms
Armanini, D., Calò, L. A., & Semplicini, A. (2003) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/713609355 · Cited by 37
The Role of the Glucocorticoid Receptor in Mineralocorticoid/Salt-Mediated Cardiac Fibrosis
Rickard, A. J., Funder, J. W., Fuller, P. J., & Young, M. J. (2006) · Endocrinology · doi:10.1210/en.2006-0658 · Cited by 36
Self-citationHalperin, M. L., & Kamel, K. S. (2000) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-78-8-587 · Cited by 37
Ullian, M. E., & Fine, J. J. (1994) · Journal of Cellular Physiology · doi:10.1002/jcp.1041610203 · Cited by 37
Neuroendocrinology of Body Fluid Homeostasis
Daniels, D., & Fluharty, S. J. (2009) · Elsevier eBooks · doi:10.1016/b978-008088783-8.00007-3 · Cited by 37
Mineralocorticoid receptors in the central nervous system
Funder, J. W. (1996) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(95)00235-9 · Cited by 37
Self-citationLong-term control of neuronal excitability by corticosteroid hormones
Joëls, M., Hesen, W., & de Kloet, E. R. (1995) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(95)00069-c · Cited by 37
Strömstedt, P. E., Berkenstam, A. L., Jörnvall, H., Gustafsson, J.-Α., & Carlstedt‐Duke, J. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)38255-9 · Cited by 37
Nuclear Receptor Regulation of Aquaporin-2 in the Kidney
Zhang, X., Wang, B., & Guan, Y. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17071105 · Cited by 36
“Both events were mediated by the MR occupancy because these effects were induced by physiological concentrations of aldosterone (10 ́9 M) and were abolished by the MR antagonist canrenoate [66,67].”
BackgroundFunder, J. W. (2017) · Journal of Endocrinology · doi:10.1530/joe-17-0119 · Cited by 36
Self-citationWu, A., Wolley, M. J., & Stowasser, M. (2019) · Journal of Human Hypertension · doi:10.1038/s41371-019-0170-6 · Cited by 36
Jackson, S. N., Williams, B., Houtman, P., & Trembath, R. C. (1998) · Journal of Medical Genetics · doi:10.1136/jmg.35.6.510 · Cited by 36
Ito, T., Morita, N., Nishi, M., & Kawata, M. (2000) · Neuroscience Research · doi:10.1016/s0168-0102(00)00112-7 · Cited by 36
“MR is distributed in the putative target tissues of mineralocorticoids such as kidney and colon, and mediates the electrolyte and water balance (Sheppard and Funder, 1987; Funder et al., 1988).”
BackgroundBray, P. J., Du, B., Mejia, V. M., Hao, S. C., Deutsch, E., Fu, C., Wilson, R. C., Hanauske-Abel, H. M., & McCaffrey, T. A. (1999) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.19.5.1180 · Cited by 36
Diederich, S., Hanke, B., Oelkers, W., & Bähr, V. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.5.3936 · Cited by 36
Isozymes of 11β-hydroxysteroid dehydrogenase: Which enzyme endows mineralocorticoid specificity?
Krozowski, Z. S., Provencher, P. H., Smith, R. E., Obeyesekere, V. R., Mercer, W., & Albiston, A. L. (1994) · Steroids · doi:10.1016/0039-128x(94)90087-6 · Cited by 36
Self-citationDevelopment of the Hypothalamic‐Pituitary‐Adrenal Axis and the Stress Response
Walker, C., Anand, K. J. S., & Plotsky, P. M. (2001) · Comprehensive Physiology · doi:10.1002/cphy.cp070412 · Cited by 35
The Adrenal Cortex and Its Disorders
Miller, W. L., Flück, C. E., Breault, D. T., & Feldman, B. J. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-62520-3.00014-2 · Cited by 35
Iqbal, J., Andrew, R., Cruden, N. L. M., Kenyon, C. J., Hughes, K. A., Newby, D. E., Hadoke, P. W. F., & Walker, B. R. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-2049 · Cited by 35
“Because physiological concentrations of cortisol are two to three orders of magnitude higher than those of aldosterone, MR can be preferentially occupied by cortisol except in cells that express the cortisolinactivating enzyme, 11 -hydroxysteroid dehydrogenase type 2 (11 -HSD2) (9, 10).”
BackgroundLienhard, D., Lauterburg, M., Escher, G., Frey, F. J., & Frey, B. M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0037898 · Cited by 35
Vieira, J. G. H., Nakamura, O. H., & Carvalho, V. M. (2014) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/0004-2730000003347 · Cited by 35
“This enzyme acts as a protector of the specificity of mineralocorticoid receptor (MR) by metabolizing cortisol to cortisone that has no affinity for the MR (31).”
BackgroundNovel mouse strain with Cre recombinase in 11β-hydroxysteroid dehydrogenase-2-expressing cells
Náray‐Fejes‐Tóth, A., & Fejes‐Tóth, G. (2006) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00188.2006 · Cited by 35
Localization of 11β-Hydroxysteroid Dehydrogenase Types 1 and 2 in the Male Reproductive Tract
Waddell, B. J., Hisheh, S., Krozowski, Z. S., & Burton, P. J. (2003) · Endocrinology · doi:10.1210/en.2003-0082 · Cited by 35
II. Intestinal corticosteroid receptors
Sheppard, K. E. (2002) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00531.2001 · Cited by 35
“(14, 19 ). The 11β-dehydrogenase activity of this enzyme, converts corticosterone and cortisol”
BackgroundVASCULAR LOCALIZATION OF THE 11β‐HYDROXYSTEROID DEHYDROGENASE TYPE II ENZYME
Smith, R. E., Little, P. J., Maguire, J. A., Stein‐Oakley, A. N., & Krozowski, Z. S. (1996) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.1996.tb02776.x · Cited by 31
Self-citationTowards selectively modulating mineralocorticoid receptor function: lessons from other systems
Baxter, J. D., Funder, J. W., Apriletti, J. W., & Webb, P. (2003) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2003.10.044 · Cited by 35
Self-citationQuinkler, M. O., Johanssen, S., Bumke‐Vogt, C., Oelkers, W., Bähr, V., & Diederich, S. (2001) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(00)00429-9 · Cited by 35
Tujague, M., Saligaut, D., Teitsma, C. A., Kah, O., Valotaire, Y., & Ducouret, B. (1998) · General and Comparative Endocrinology · doi:10.1006/gcen.1998.7066 · Cited by 35
The activities of 5β-reductase and 11β-hydroxysteroid dehydrogenase in essential hypertension
Iki, K., Miyamori, I., Hatakeyama, H., Yoneda, T., Takeda, Y., Takeda, R., & Dai, Q.-L. (1994) · Steroids · doi:10.1016/0039-128x(94)90022-1 · Cited by 35
Fries, R. S., Mahboubi, P., Mahapatra, N. R., Mahata, S. K., Schork, N. J., Schmid-Schöenbein, G. W., & O’Connor, D. T. (2004) · Hypertension · doi:10.1161/01.hyp.0000127708.96195.e6 · Cited by 35
Genetic disorders of steroid hormone synthesis and metabolism
New, M. I., & White, P. C. (1995) · Baillière s Clinical Endocrinology and Metabolism · doi:10.1016/s0950-351x(95)80587-7 · Cited by 35
Obeid, J. (1993) · Molecular Endocrinology · doi:10.1210/me.7.2.154 · Cited by 34
Edwards, C. R. W., & Stewart, P. M. (1991) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(91)90036-5 · Cited by 35
Baker, M. E. (2010) · Nature Precedings · doi:10.1016/j.febslet.2010.03.036 · Cited by 35
“If indeed, 11b-HSD1 and 11b-HSD2 first evolved in sharks, then this dates the evolution of the 11b-HSD1/11b-HSD2 mechanism for regulating tissue-specific actions of glucocorticoids [5,6,35].”
Background11β-Hydroxysteroid Dehydrogenase Type 2 and Mineralocorticoid Receptor in Human Fetal Development
Hirasawa, G., Sasano, H., Suzuki, T., Takeyama, J., Muramatu, Y., Fukushima, K., Hiwatashi, N., Toyota, T., Nagura, H., & Krozowski, Z. S. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.4.5615 · Cited by 34
“II (11bHSD2) is thought to confer specificity on the nonselective mineralocorticoid receptor (MR) (1) by converting glucocorticoids to their receptor inactive metabolites, thereby allowing the much lower circulating level of aldosterone to bind to MR (2, 3 ). 11bHSD2 has been reported in adult human mineralocorticoid…”
BackgroundCorticosteroid receptors adopt distinct cyclical transcriptional signatures
Billan, F. L., Amazit, L., Bleakley, K., Xue, Q.-Y., Pussard, E., Lhadj, C., Kolkhof, P., Viengchareun, S., Fagart, J., & Lombès, M. (2018) · The FASEB Journal · doi:10.1096/fj.201800391rr · Cited by 34
“Epithelial tissues, classic MR targets, express the 11b-hydroxysteroid dehydrogenase type 2 enzyme (11bHSD2), which converts glucocorticoids into their 11-dehydroderivatives; cortisol into cortisone, and corticosterone into 11-dehydrocorticosterone, that are almost unable to activateMRs, which allows selective access…”
BackgroundThe Basics of the Stress Response: A Historical Context and Introduction
Thiel, K. J., & Dretsch, M. N. (2011) · Wiley eBooks · doi:10.1002/9781118083222.ch1 · Cited by 34
Role of mineralocorticoid action in the brain in salt‐sensitive hypertension
Oki, K., Gómez-Sánchez, E. P., & Gómez-Sánchez, C. E. (2011) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2011.05538.x · Cited by 34
Stewart, P. M., & Newell-Price, J. D. C. (2016) · Elsevier eBooks · doi:10.1016/b978-0-323-29738-7.00015-0 · Cited by 34
MODULATION OF TRANSALVEOLAR FLUID ABSORPTION BY ENDOGENOUS ALDOSTERONE IN ADULT RATS
Suzuki, H. T. S. (2001) · Experimental Lung Research · doi:10.1080/019021401750069384 · Cited by 34
Effects of herbal supplements on the kidney.
Combest, W. L., Newton, M., Combest, A. J., & Kosier, J. H. (2005) · PubMed · Cited by 34
Rothuizen, J. J., Biewenga, W. J., & Mol, J. A. (1995) · Domestic Animal Endocrinology · doi:10.1016/0739-7240(94)00005-l · Cited by 34
Genetic Factors in Hypertension – What is Known and What Does It Mean?
Melander, O. (2001) · Blood Pressure · doi:10.1080/080370501753400575 · Cited by 34
“by 11bHSD2, as cortisone does not bind to the receptor [66, 70, 71].”
BackgroundMaternal Hypertension and Progeny Blood Pressure: Role of Aldosterone and 11β-HSD
Gómez-Sánchez, E. P., & Gómez-Sánchez, C. E. (1999) · Hypertension · doi:10.1161/01.hyp.33.6.1369 · Cited by 34
Development of renal function in the fetus: a review
Lumbers, E. R. (1995) · Reproduction Fertility and Development · doi:10.1071/rd9950415 · Cited by 34
Effects of Glycyrrhizin on Production of Vascular Aldosterone and Corticosterone
Wu, P., Zhang, Y., Liu, Y., Wang, X., Guo, Z., Zhang, Y., Liang, X., & Lai, W. (1999) · Hormone Research in Paediatrics · doi:10.1159/000023356 · Cited by 34
McEwen, B. S., Brinton, R. D., Chao, H. M., Coirini, H., Gannon, M. N., Gould, E., O'Callaghan, J. P., Spencer, R. L., Sakai, R. R., & Woolley, C. S. (1990) · Neuroendocrine perspectives · doi:10.1007/978-1-4612-3446-3_4 · Cited by 34
McMillen, I. C., Warnes, K. E., Adams, M. B., Robinson, J. S., Owens, J. A., & Coulter, C. L. (2000) · Endocrinology · doi:10.1210/endo.141.2.7338 · Cited by 34
Editorial: Steroid Transformation Enzymes as Critical Regulators of Steroid Action in Vivo
Song, W., & Melner, M. H. (2000) · Endocrinology · doi:10.1210/endo.141.5.7526 · Cited by 34
Therapeutic targeting of aldosterone: a novel approach to the treatment of glomerular disease
Brem, A. S., & Gong, R. (2015) · Clinical Science · doi:10.1042/cs20140432 · Cited by 33
Bae, S.-A., & Androulakis, I. P. (2017) · Gene Regulation and Systems Biology · doi:10.1177/1177625017702393 · Cited by 33
Bocchi, B., Kenouch, S., Lamarre-Cliché, M., Muffat‐Joly, M., Capron, M. H., Fiet, J., Morineau, G., Azizi, M., Bonvalet, J. P., & Farman, N. (2004) · Hypertension · doi:10.1161/01.hyp.0000121362.64182.ad · Cited by 33
“25 Pools of sweat gland ducts (2 to 4 fragments, 3-mm total length, ie, 1500 cells per assay) were transferred in 5 L medium into ice-cold Eagle minimal essential medium (MEM) culture medium (5 L) containing 10 nmol/L [1,2,6,7]-(3)H corticosterone (2.”
MethodModulation of Renal Calcium Handling by 11β-Hydroxysteroid Dehydrogenase Type 2
Ferrari, P., Bianchetti, M. G., Sansonnens, A., & Frey, F. J. (2002) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000028640.78526.0f · Cited by 33
Herkert, P. F., Hagen, F., Salvador, G. L. D. O., Gomes, R. R., Ferreira, M. S., Vicente, V. A., Muro, M. D., Pinheiro, R. L., Meis, J. F. G. M., & Queiroz‐Telles, F. (2016) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-016-2731-8 · Cited by 33
The Adrenal Cortex and Its Disorders
Miller, W. L., Achermann, J. C., & Flück, C. E. (2008) · Elsevier eBooks · doi:10.1016/b978-141604090-3.50017-x · Cited by 33
Ferguson, S., Pallikaros, Z., Michael, A. E., & COOKE, B. A. (1999) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(99)00186-0 · Cited by 33
Glucocorticoid and Growth Factor Synergism Requirement for Notch4 Chromatin Domain Activation
Wu, J., & Bresnick, E. H. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.02152-06 · Cited by 33
“Cortisol activates the GR, but can activate the mineralocorticoid receptor in certain contexts (11).”
BackgroundMineralocorticoid Action in the Aldosterone-Sensitive Distal Nephron
Verrey, F., Hümmler, E., Schild, L., & Rossier, B. C. (2008) · Elsevier eBooks · doi:10.1016/b978-012088488-9.50035-8 · Cited by 33
Why are mineralocorticoid receptors so nonselective?
Funder, J. W. (2007) · Current Hypertension Reports · doi:10.1007/s11906-007-0020-8 · Cited by 33
“The demonstration of the co-expression of the glucocorticoid metabolizing enzyme 11C hydroxysteroid dehydrogenase (11CHSD2) with epithelial MR holds the key to their selectivity in epithelia [ 6 ,7].”
BackgroundSelf-citation11β-Hydroxysteroid dehydrogenase in human vascular cells
Hatakeyama, H., Inaba, S., Takeda, R., & Miyamori, I. (2000) · Kidney International · doi:10.1046/j.1523-1755.2000.00974.x · Cited by 33
Souness, G. W., & Morris, D. J. (1991) · Endocrinology · doi:10.1210/endo-129-5-2451 · Cited by 33
Licorice ingestion and blood pressure regulating hormones
Schambelan, M. (1994) · Steroids · doi:10.1016/0039-128x(94)90089-2 · Cited by 33
A second enzyme protecting mineralocorticoid receptors from glucocorticoid occupancy
Morris, D. J., Latif, S. A., Rokaw, M. D., Watlington, C. O., & Johnson, J. P. (1998) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1998.274.5.c1245 · Cited by 33
“(11) proposed that, in vivo, renal MR remains aldosterone specific because the enzyme, 11bhydroxysteroid dehydrogenase (11b-HSD), metabolized glucocorticoids to their respective 11-dehydro products (5), which have low binding affinities for MR, do not elicit mineralocorticoid-like effects, and are considered inactive…”
BackgroundMultiple patterns of 11β-hydroxysteroid dehydrogenase catalytic activity along the mammalian nephron
Kenouch, S., Coutry, N., Farman, N., & Bonvalet, J. P. (1992) · Kidney International · doi:10.1038/ki.1992.260 · Cited by 33
Slight, S. H., Ganjam, V. K., Nonneman, D., & Weber, K. T. (1993) · PubMed · Cited by 33
Inhibition of 11β-hydroxysteroid dehydrogenase and its effect on epithelial sodium transport
Hierholzer, K., Siebe, H., & Fromm, M. (1990) · Kidney International · doi:10.1038/ki.1990.258 · Cited by 33
“146), has recently been implicated in mediating mineralocorticoid specificity of corticosteroid receptors [5—7]) It is this concept we address in the present paper.”
BackgroundAldosterone, hypertension and heart failure: insights from clinical trials
Funder, J. W. (2010) · Hypertension Research · doi:10.1038/hr.2010.115 · Cited by 32
Self-citationBienvenu, L. A., Reichelt, M. E., Delbridge, L. M. D., & Young, M. J. (2013) · Clinical Science · doi:10.1042/cs20130050 · Cited by 32
Rago, D., Mette, K., Gürdeniz, G., Marini, F., Poulsen, M., & Dragsted, L. O. (2013) · Metabolomics · doi:10.1007/s11306-013-0534-9 · Cited by 32
“The 11b-HSD2 in the distal nephron inactivates corticosteroids in order to make the aldosterone functionally significant (Stewart et al. 1987; Funder et al. 1988).”
Brocca, M. E., Pietranera, L., Meyer, M., Lima, A. E., Roig, P., de Kloet, E. R., & Nicola, A. F. D. (2017) · Journal of Neuroendocrinology · doi:10.1111/jne.12489 · Cited by 32
The cross talk of adrenal and Leydig cell steroids in Leydig cells
Wang, Y., Li, H., Zhu, Q., Li, X., Lin, Z., & Ge, R. (2019) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2019.105386 · Cited by 32
Kasuya, Y., Shibasaki, H., & Furuta, T. (2000) · Steroids · doi:10.1016/s0039-128x(99)00086-0 · Cited by 32
Shimoyama, Y., Hirabayashi, K., Matsumoto, H., Sato, T., Shibata, S., & Inoue, H. (2003) · Journal of Pharmacy and Pharmacology · doi:10.1211/002235703765951429 · Cited by 32
“Studies of glucocorticoid metabolism have led to the hypothesis that glycyrrhetinic acid and other similar liquorice derivatives may express their mineralocorticoid-like actions by inhibiting 11 - HSD (Stewart et al 1987; Edwards et al 1988; Funder et al 1988).”
BackgroundInteractions between 11β-hydroxysteroid dehydrogenase and COX-2 in kidney
Yao, B., Harris, R. C., & Zhang, M. (2005) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00786.2004 · Cited by 32
Metadata
- Authors
- Funder, J. W., Pearce, P. T., Smith, R., & Smith, A. I.
- Affiliations
- Medical Research Centre, Prince Henry's Hospital, Melbourne, Australia 3004.
- Venue
- Science
- Published
- 1988-10-28
- Volume
- 242
- Issue
- 4878
- Pages
- 583-585
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2148114970
- Semantic Scholar
- ae47dabb539e84fc85ea0bfd3f1a669037f37264
- Cited by
- 1,628
- References
- 19
- Citations by year
- 2026: 15 · 2025: 7 · 2024: 21 · 2023: 21 · 2022: 16 · 2021: 25 · 2020: 25 · 2019: 32 · 2018: 32 · 2017: 33 · 2016: 26 · 2015: 30 · 2014: 37 · 2013: 44 · 2012: 56
- FWCI
- 30.19
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal Regulation and Hypertension
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Keywords
- mineralocorticoid receptor, aldosterone, glucocorticoids, cortisol, corticosterone, 11β-hydroxysteroid dehydrogenase, 11-keto steroids, kidney, parotid gland, colon, hippocampus, heart
- MeSH terms
- Adrenalectomy, Aldosterone, Animals, Carbenoxolone, Colon, Corticosterone, Heart, Hippocampus, Hydrocortisone, Hydroxysteroid Dehydrogenases, Kidney, Parotid Gland, Receptors, Steroid, Receptors, Mineralocorticoid, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.